glp-1 before pregnancy medications like Ozempic, Wegovy and Mounjaro are changing diabetes and weight management, but they aren't recommended during or while nursing. The current recommendation is to stop conception and discuss GLP-1 agonists' safety during pregnancy

[5] This suggests that the hair loss is primarily a consequence of the weight reduction itself rather than a specific drug effect

GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation

Focusing the inhibition of NMDA receptors specifically on neurons expressing the GLP-1 receptor is essential for achieving this effect

Full safety information, provider consultation requirements, and restrictions, are available at Midis mission is to revolutionize healthcare for women at midlife, wherever they live and whatever their health story

Whilst injectable GLP-1 therapies such as semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda) are well established in UK clinical practice, transdermal patch formulations represent an emerging area of pharmaceutical development

Tirzepatide has emerged as a promising option for those struggling with weight management and type 2 diabetes